These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 26492953)

  • 1. The association of thiol/disulphide homeostasis and lipid accumulation index with cardiovascular risk factors in overweight adolescents with polycystic ovary syndrome.
    Ozler S; Oztas E; Tokmak A; Ergin M; Isci E; Eren F; Pehlivan S; Neselioglu S; Yılmaz N
    Clin Endocrinol (Oxf); 2016 Apr; 84(4):516-23. PubMed ID: 26492953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of serum human Klotho levels and thiol/disulfide homeostasis in women with polycystic ovary syndrome and in healthy women.
    Biyik I; Erten O; Isiklar OO; Ince O; Soysal C; Berikten D; Mammadli S; Oztas E
    Taiwan J Obstet Gynecol; 2021 May; 60(3):487-491. PubMed ID: 33966733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased oxidative stress is associated with thiol/disulphide homeostasis in clomiphene citrate resistant polycystic ovary syndrome.
    Ege S; Bademkıran MH; Peker N; Özgün Z; Bağlı İ; Erdem S; Erel Ö; Özgökçe Ç; Gül E
    J Obstet Gynaecol; 2021 Apr; 41(3):467-470. PubMed ID: 32586152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The predictive effect of inflammatory markers and lipid accumulation product index on clinical symptoms associated with polycystic ovary syndrome in nonobese adolescents and younger aged women.
    Tola EN; Yalcin SE; Dugan N
    Eur J Obstet Gynecol Reprod Biol; 2017 Jul; 214():168-172. PubMed ID: 28535403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of dynamic thiol-disulfide homeostasis and inflammatory markers in patients with polycystic ovary syndrome.
    Aydın GA; Turan Özsoy HG; Ankaralı H; Özgen G; Neşelioğlu S
    Taiwan J Obstet Gynecol; 2020 Jan; 59(1):79-84. PubMed ID: 32039805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic Thiol-Disulphide Status in Polycystic Ovary Syndrome and Its Association with the Pathogenesis of the Disease.
    Yildirim M; Turkyilmaz E; Neselioglu S; Alisik M; Avsar AF
    Gynecol Obstet Invest; 2017; 82(1):54-59. PubMed ID: 27092788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease.
    Meyer C; McGrath BP; Teede HJ
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5711-6. PubMed ID: 16046590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow-mediated dilatation in overweight and obese women with polycystic ovary syndrome.
    Brinkworth GD; Noakes M; Moran LJ; Norman R; Clifton PM
    BJOG; 2006 Nov; 113(11):1308-14. PubMed ID: 17059392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased levels of serum granzyme-B is associated with insulin resistance and increased cardiovascular risk in adolescent polycystic ovary syndrome patients.
    Oztas E; Ozler S; Tokmak A; Yilmaz N; Celik HT; Kazancı FH; Danisman N; Ergin M; Yakut HI
    Eur J Obstet Gynecol Reprod Biol; 2016 Mar; 198():89-93. PubMed ID: 26802256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comprehensive assessment of endothelial function in overweight women with and without polycystic ovary syndrome.
    Moran LJ; Hutchison SK; Meyer C; Zoungas S; Teede HJ
    Clin Sci (Lond); 2009 May; 116(10):761-70. PubMed ID: 18851710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid accumulation product index: a reliable marker of cardiovascular risk in polycystic ovary syndrome.
    Wiltgen D; Benedetto IG; Mastella LS; Spritzer PM
    Hum Reprod; 2009 Jul; 24(7):1726-31. PubMed ID: 19329517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating levels of obestatin and copeptin in obese and nonobese women with polycystic ovary syndrome.
    Taskin MI; Bulbul E; Adali E; Hismiogulları AA; Inceboz U
    Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():19-23. PubMed ID: 25837320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of aerobic exercise capacity and muscle strength in overweight women with and without polycystic ovary syndrome.
    Thomson RL; Buckley JD; Moran LJ; Noakes M; Clifton PM; Norman RJ; Brinkworth GD
    BJOG; 2009 Aug; 116(9):1242-50. PubMed ID: 19438498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detailed characterisation of circulatory nitric oxide and free radical indices--is there evidence for abnormal cardiovascular homeostasis in young women with polycystic ovary syndrome?
    Willis GR; Udiawar M; Evans WD; Blundell HL; James PE; Rees DA
    BJOG; 2014 Dec; 121(13):1596-603. PubMed ID: 24816317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low plasma atrial natriuretic peptide: a new piece in the puzzle of polycystic ovary syndrome.
    Lauria PB; Del Puerto HL; Reis AM; Candido AL; Reis FM
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4882-9. PubMed ID: 24057296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance and its relationship with high molecular weight adiponectin in adolescents with polycystic ovary syndrome and a maternal history of polycystic ovary syndrome.
    Cankaya S; Demir B; Aksakal SE; Dilbaz B; Demirtas C; Goktolga U
    Fertil Steril; 2014 Sep; 102(3):826-30. PubMed ID: 24973036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diverse impacts of aging on insulin resistance in lean and obese women with polycystic ovary syndrome: evidence from 1345 women with the syndrome.
    Livadas S; Kollias A; Panidis D; Diamanti-Kandarakis E
    Eur J Endocrinol; 2014 Sep; 171(3):301-9. PubMed ID: 25053727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of serum anti-Müllerian hormone levels in normal weight and overweight-obese adolescent patients with polycystic ovary syndrome.
    Cengiz H; Ekin M; Dagdeviren H; Yildiz Ş; Kaya C; Kanawati A
    Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():46-50. PubMed ID: 25036408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome.
    Yilmaz SA; Kerimoglu OS; Pekin AT; Incesu F; Dogan NU; Celik C; Unlu A
    Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():56-60. PubMed ID: 25020276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.